Mechanical ventilation in patients with idiopathic pulmonary fibrosis in Korea: a nationwide cohort study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The prognosis of patients with idiopathic pulmonary fibrosis (IPF) and respiratory failure requiring mechanical ventilation is poor. Therefore, mechanical ventilation is not recommended. Recently, outcomes of mechanical ventilation, including those for patients with IPF, have improved. The aim of this study was to investigate changes in the use of mechanical ventilation in patients with IPF and their outcomes over time. Methods: This retrospective, observational cohort study used data from the National Health Insurance Service database. Patients diagnosed with IPF between January 2011 and December 2019 who were placed on mechanical ventilation were included. We analyzed changes in the use of mechanical ventilation in patients with IPF and their mortality using the Cochran- Armitage trend test. Results: Between 2011 and 2019, 1,227 patients with IPF were placed on mechanical ventilation. The annual number of patients with IPF with and without mechanical ventilation increased over time. However, the ratio was relatively stable at approximately 3.5%. The overall hospital mortality rate was 69.4%. There was no improvement in annual hospital mortality rate. The overall 30-day mortality rate was 68.7%, which did not change significantly. The overall 90-day mortality rate was 85.3%. The annual 90-day mortality rate was decreased from 90.9% in 2011 to 83.1% in 2019 (p = 0.028). Conclusions: Despite improvements in intensive care and ventilator management, the prognosis of patients with IPF receiving mechanical ventilation has not improved significantly.
Abstract
Background/Aims: The prognosis of patients with idiopathic pulmonary fibrosis (IPF) and respiratory failure requiring mechanical ventilation is poor. Therefore, mechanical ventilation is not recommended. Recently, outcomes of mechanical ventilation, including those for patients with IPF, have improved. The aim of this study was to investigate changes in the use of mechanical ventilation in patients with IPF and their outcomes over time. Methods: This retrospective, observational cohort study used data from the National Health Insurance Service database. Patients diagnosed with IPF between January 2011 and December 2019 who were placed on mechanical ventilation were included. We analyzed changes in the use of mechanical ventilation in patients with IPF and their mortality using the Cochran- Armitage trend test. Results: Between 2011 and 2019, 1,227 patients with IPF were placed on mechanical ventilation. The annual number of patients with IPF with and without mechanical ventilation increased over time. However, the ratio was relatively stable at approximately 3.5%. The overall hospital mortality rate was 69.4%. There was no improvement in annual hospital mortality rate. The overall 30-day mortality rate was 68.7%, which did not change significantly. The overall 90-day mortality rate was 85.3%. The annual 90-day mortality rate was decreased from 90.9% in 2011 to 83.1% in 2019 (p = 0.028). Conclusions: Despite improvements in intensive care and ventilator management, the prognosis of patients with IPF receiving mechanical ventilation has not improved significantly.
참고문헌 (34)
- Kaul B, "Variability in global prevalence of interstitial lung disease", Front Med(Lausanne), 8, pp.751181~ (2021)
- Khor YH, "Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy : a systematic review", Eur Respir Rev, 29, pp.190158~ (2020)
- Collard HR, "Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report", Am J Respir Crit Care Med, 194, pp.265~275 (2016)
- Mallick S, "Outcome of patients with idiopathic pulmonary fibrosis(IPF)ventilated in intensive care unit", Respir Med, 102, pp.1355~1359 (2008)
- Raghu G, "An official ATS", ERS, ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management, pp.Am J Respir Crit Care Med, 2011[DOI]
- Raghu G, "An official ATS", ERS, ALAT clinical practice guideline : treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline, pp.Am J Respir Crit Care Med, 2015[DOI]
- Esteban A, "Evolution of mortality over time in patients receiving mechanical ventilation", Am J Respir Crit Care Med, 188, pp.220~230 (2013)
- Peñuelas O, "Inter-country variability over time in the mortality of mechanically ventilated patients", Intensive Care Med, 46, pp.444~453 (2020)
- Huapaya JA, "Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit", Eur Respir Rev, 27, pp.180061~ (2018)
- Rush B, "The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States : a nationwide retrospective cohort analysis", Respir Med, 111, pp.72~76 (2016)
- Silva Santos P, "Mechanical ventilation in idiopathic pulmonary fibrosis : unresolved dilemma", Respir Med, 117, pp.283~ (2016)
- Rush B, "Reply to letter to the editor-Mechanical ventilation in idiopathic pulmonary fibrosis : unresolved dilemma", Respir Med, 117, pp.284~ (2016)
- "Population coverage 2020" (2020)[URL]
- Mooney JJ, "Mechanical ventilation in idiopathic pulmonary fibrosis : a nationwide analysis of ventilator use, outcomes, and resource burden", BMC Pulm Med, 17, pp.84~ (2017)
- Alqalyoobi S, "In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017 : a comparison of academic and non-academic programs", BMC Pulm Med, 20, pp.289~ (2020)
- Kim HJ, "Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012 : a nationwide population-based study", Inflamm Bowel Dis, 21, pp.623~630 (2015)
- Luo Z, "Mechanical ventilation for acute respiratory failure due to idiopathic pulmonary fibrosis versus connective tissue disease-associated interstitial lung disease : effectiveness and risk factors for death", Clin Respir J, 14, pp.918~932 (2020)
- Gannon WD, "Outcomes and mortality prediction model of critically Ill adults with acute respiratory failure and interstitial lung disease", Chest, 153, pp.1387~1395 (2018)
- Salonen J, "Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases", BMJ Open Respir Res, 7, pp.e000563~ (2020)
- Fernández-Pérez ER, "Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease", Chest, 133, pp.1113~1119 (2008)
- Lee JH, "Highflow nasal cannula oxygen therapy in idiopathic pulmonary fibrosis patients with respiratory failure", J Thorac Dis, 12, pp.966~972 (2020)
- Salonen J, "Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases", PLoS One, 15, pp.e0242860~ (2020)
- Smith RA, "The characteristics and outcomes of patients with idiopathic pulmonary fibrosis admitted to the ICU with acute respiratory failure", Heart Lung, 50, pp.192~196 (2021)
- Moua T, "Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening : a large cohort analysis", Chest, 149, pp.1205~1214 (2016)
- Kondoh Y, "Thrombomodulin alfa for acute exacerbation of idiopathic pulmonary fibrosis. A randomized, double-blind placebo-controlled trial", Am J Respir Crit Care Med, 201, pp.1110~1119 (2020)
- Naccache JM, "Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis(EXAFIP) : a randomised, double-blind, placebo-controlled, phase 3 trial", Lancet Respir Med, 10, pp.26~34 (2022)
- Caminati A, "Epidemiological studies in idiopathic pulmonary fibrosis : pitfalls in methodologies and data interpretation", Eur Respir Rev, 24, pp.436~444 (2015)
- Raghu G, "Diagnosis of idiopathic pulmonary fibrosis. an official ATS", ERS, ALAT clinical practice guideline, pp.Am J Respir Crit Care Med, 2018[DOI]
- Kato M, "Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis : a retrospective study", Respir Res, 20, pp.287~ (2019)
- Moon SW, "Longitudinal changes in clinical features, management, and outcomes of idiopathic pulmonary fibrosis. A nationwide cohort study", Ann Am Thorac Soc, 18, pp.780~787 (2021)
- Jegal Y, "Clinical features, diagnosis, management, and outcomes of idiopathic pulmonary fibrosis in Korea : analysis of the Korea IPF Cohort(KICO)registry", Tuberc Respir Dis(Seoul), 85, pp.185~194 (2022)
- Kang J, "Antifibrotic treatment improves clinical outcomes in patients with idiopathic pulmonary fibrosis : a propensity score matching analysis", Sci Rep, 10, pp.15620~ (2020)
- Raghu G, "Idiopathic pulmonary fibrosis(an update)and progressive pulmonary fibrosis in adults : an Official ATS", ERS, ALAT clinical practice guideline, pp.Am J Respir Crit Care Med, 2022[DOI]
- Jeong YH, "Current status of lung transplantation in Korea", Curr Chall Thorac Surg, 4, pp.4~ (2022)